FIELD: medicine.
SUBSTANCE: invention represents an antifungal preparation in suppositories for children containing recombinant human interferon 2α and fluconazole, wherein lysozyme, Licopid and dimephosphone are additionally introduced.
EFFECT: preparation possesses the high clinical effectiveness in the fungal diseases in children that leads to reducing the length of treatment and prolonging the intercurrent period.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG PREPARATION IN SUPPOSITORIES FOR INFECTIOUS-INFLAMMATORY DISORDERS CAUSED BY TYPE 1 HERPES SIMPLEX AND CYTOMEGALOVIRUS, AND METHOD FOR USING IT FOR TREATING CHILDREN | 2013 |
|
RU2521272C1 |
CHIMERIC RECOMBINANT INTERFERON ALPHA-2B, HAVING ANTIFUNGAL ACTIVITY | 2024 |
|
RU2823607C1 |
CURATIVE AGENT | 2005 |
|
RU2283133C1 |
METHOD FOR TREATMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS | 2016 |
|
RU2642666C1 |
DRUG AND METHOD OF TREATING INFECTIOUS AND INFLAMMATORY DISEASES | 2009 |
|
RU2414927C1 |
METHOD FOR TREATMENT OF VAGINAL CANDIDOSIS | 2004 |
|
RU2254857C1 |
METHOD OF TREATING ULCEROUS DISEASE OF DUODENUM IN CHILDREN, ASSOCIATED WITH FUNGUS OF GENUS Candida | 2009 |
|
RU2416405C1 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
METHOD FOR TREATMENT AND PREVENTION OF ORAL COMPLICATIONS CAUSED BY HORMONAL PREPARATION INHALATIONS IN PATIENTS SUFFERING BRONCHIAL ASTHMA | 2012 |
|
RU2506080C1 |
MEDICINAL FOR VAGINAL APPLICATION, WITH ANTIVIRAL, ANTIMICROBIAL, ANTIFUNGAL, ANTIPROTOZOAL, ANTIINFECTIOUS, IMMUNOMODULATING AND ANTIINFLAMMATORY ACTION, AS OINTMENT, GEL, SUPPOSITORY | 2016 |
|
RU2633056C1 |
Authors
Dates
2014-12-10—Published
2013-08-20—Filed